![Tim Coughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 31/08/2026
Timothy P.
Coughlin is Chairman at aTyr Pharma, Inc. since 2024.
He is a Non-Executive Director at ADC Therapeutics SA starting in 2025.
He serves as an Independent Director at Travere Therapeutics, Inc. since 2015.
He is a Director at Vir Biotechnology, Inc. beginning in 2026.
Former roles include Independent Director at Fate Therapeutics, Inc. from 2015 to 2025, Director at Peloton Therapeutics, Inc. in 2019, Senior Manager-Health Sciences Practice at Ernst & Young LLP from 1989 to 1999, Chief Financial Officer at Neurocrine Biosciences, Inc., and Vice President-Financial Services at CommonSpirit Health from 1999 to 2002.
Education includes a graduate degree from San Diego State University conferred in 2002 and an undergraduate degree from Temple University (Pennsylvania) conferred in 1989.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/06/2026 | 56.250 ( 0,06 % ) | 4 M $ | 31/08/2026 | |
ADC THERAPEUTICS LTD 0,06 % | 03/06/2026 | 72.400 ( 0,06 % ) | 84 708 $ | 31/08/2026 |
ATYR PHARMA, INC. 0,06 % | 27/08/2026 | 56.000 ( 0,06 % ) | 29 792 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Miembro de la Junta | 31/03/2015 |
| ATYR PHARMA, INC. | Presidente | 14/03/2024 |
| ADC THERAPEUTICS SA | Director/Miembro de la Junta | 01/06/2025 |
| VIR BIOTECHNOLOGY, INC. | Director/Miembro de la Junta | 09/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Miembro de la Junta | 29/05/2025 |
| PELOTON THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/12/2019 |
CommonSpirit Health (Illinois)
 CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Director Financiero/CFO | 01/01/2002 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/01/1999 |
| NEUROCRINE BIOSCIENCES, INC. | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Commercial Services |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
